ubmslateOT-logo-ubm

OT mobile menu

Search form

Topics:

Hematologic Cancer Targets

Is Cytomegalovirus Linked to Childhood Leukemia Risk?

These findings suggest the possibility that ALL could be prevented with antiviral interventions or vaccination. Image © Jarun Ontakrai/Shutterstock.com 

Hematologic Cancer Targets

Researchers at the Mayo Clinic are reporting that they have identified a new therapy that shrinks tumors in patients with multiple myeloma.

We spoke with Dr. Anas Younes about the molecular characteristics of diffuse large B-cell lymphoma.

The emergence of ibrutinib-resistant chronic lymphocytic leukemia (CLL) can be detected prior to clinical relapse, according to an analysis of patients from four ibrutinib trials.

Genetic profiling combined with clinical factors may help guide clinicians on how to better manage patients with myelodysplastic syndrome.

Despite significant toxicities, idelalisib improved time to progression for patients with treatment-resistant chronic lymphoblastic leukemia.

Combined miniCHOP and treatment with the fully-human anti-CD20 monoclonal antibody ofatumumab is associated with improved overall survival among elderly patients diagnosed with diffuse large B-cell lymphoma.

Stem cells that give rise to acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) express higher levels of the CD99 cell surface protein-sugar molecule than normal stem cells.

Pages

Subscribe to Hematologic Cancer Targets on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.